| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2008 | US20080051420 New Compounds 317 |
| 02/28/2008 | US20080051419 Amine derivatives useful as anticancer agents |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051417 Uses of selective cyclooxygenase-1 inhibitors |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080051415 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051413 Nitrophenylpiperazine derivative of xanthine which relaxes tracheal airway and increases respiratory performance |
| 02/28/2008 | US20080051412 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds and their Uses |
| 02/28/2008 | US20080051411 choline fenofibrate, or fenofibric acid salts of ethanolamine, diethanolamine, piperazine, calcium or tromethamine; salts have improved photostability; hyperlipidemia or coronary heart diseases |
| 02/28/2008 | US20080051410 Protein Kinase Targeted Therapeutics |
| 02/28/2008 | US20080051409 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof |
| 02/28/2008 | US20080051408 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders |
| 02/28/2008 | US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents |
| 02/28/2008 | US20080051406 Brimonidine and timolol compositions |
| 02/28/2008 | US20080051405 Therapeutic Agents |
| 02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 02/28/2008 | US20080051403 Treatment For Alzheimer's Disease And Related Conditions |
| 02/28/2008 | US20080051402 Method of inhibiting c-kit kinase |
| 02/28/2008 | US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 02/28/2008 | US20080051400 Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| 02/28/2008 | US20080051399 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 02/28/2008 | US20080051398 Method of treating brain cancer |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051396 Costunolide derivatives |
| 02/28/2008 | US20080051395 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors |
| 02/28/2008 | US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 02/28/2008 | US20080051393 Novel cannabinoids and methods of use |
| 02/28/2008 | US20080051392 Pharmaceutical combinations for the treatment of respiratory diseases |
| 02/28/2008 | US20080051390 Such as 8-[3-(2-Fluoropyridin-3-yl)phenyl]-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine; amyloid disorders, Alzheimer's disease, Down's syndrome |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051388 Novel Compounds That Inhibit Factor Xa Activity |
| 02/28/2008 | US20080051387 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 02/28/2008 | US20080051386 Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators |
| 02/28/2008 | US20080051385 Ocular allergy treatments |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | US20080051383 Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders |
| 02/28/2008 | US20080051382 Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride |
| 02/28/2008 | US20080051381 Suppression of estrus in mares by a single injection method |
| 02/28/2008 | US20080051380 Methods and compositions for treating cancer |
| 02/28/2008 | US20080051379 Compositions and Methods for the Treatment of Peripheral B-Cell Neoplasms |
| 02/28/2008 | US20080051378 Combinations Comprising Antimuscarinic Agents and Corticosteroids |
| 02/28/2008 | US20080051377 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 02/28/2008 | US20080051376 Method for Producing Albumin-Corticoid Conjugates |
| 02/28/2008 | US20080051375 Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
| 02/28/2008 | US20080051374 ophthalmically acceptable for reducing intraocular pressure |
| 02/28/2008 | US20080051373 Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 02/28/2008 | US20080051372 Methods utilizing cell-signaling lysophospholipids |
| 02/28/2008 | US20080051371 Membrane permeable; ischemia, heart failure, and neurodegenerative disorders |
| 02/28/2008 | US20080051370 Ruthenium Complexes For Treating Cancers |
| 02/28/2008 | US20080051368 Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells |
| 02/28/2008 | US20080051367 Hyaluronan used in improvement of anti-oxidation and proliferation in chondrocytes |
| 02/28/2008 | US20080051366 Aminosugar, glycosaminoglycan, and s-adenoslymethionine composition for the treatment and repair of connective tissue |
| 02/28/2008 | US20080051365 Treatment of Inflammation |
| 02/28/2008 | US20080051364 Therapeutic Treatment of Accelerated Bone Resorption |
| 02/28/2008 | US20080051363 G-rich polynucleotides as a novel therapeutic for the treatment of huntington's disease |
| 02/28/2008 | US20080051362 Breast and prostate cancer; antisense oligodeoxynucleotides as antiproliferative agents; apoptosis |
| 02/28/2008 | US20080051361 Intraocular pressure-related conditions, namely glaucoma; administering to the eye of the patient an interfering RNA molecule that attenuates expression of the GREM1 mRNA via RNA interference |
| 02/28/2008 | US20080051360 Pkc ligands and polynucleotides encoding pkc ligands |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051358 using CLN2 protein having pepstatin-insensitive carboxyl protease activity to treat LINCL; mutation or absence of CLN2 is causative of classical late infantile neuronal ceroid lipofuscinosis (LINCL) |
| 02/28/2008 | US20080051357 Composition for attenuating neuropathic pain comprising a recombinant ventor expressing gad65 |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051353 Avermectin And Avermectin Monosaccharide Substituted In The 4"- And 4" Position Respectively |
| 02/28/2008 | US20080051352 Novel process for the preparation of telithromycin |
| 02/28/2008 | US20080051351 Substances, Compositions, and Methods for Treating Alopecia |
| 02/28/2008 | US20080051350 inulin sulphate for treatment or prophylaxis of arthritis, osteoarthritis |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051342 TRPS1-mediated modulation of hair growth |
| 02/28/2008 | US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051337 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 02/28/2008 | US20080051330 Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses |
| 02/28/2008 | US20080051329 FSH and FSH variant formulations, products and methods |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use |
| 02/28/2008 | US20080051325 Oligopeptide |
| 02/28/2008 | US20080051324 Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis |
| 02/28/2008 | US20080051323 Chloroquine drug compositions and methods for their synthesis |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080051319 Inhibiting JNK Signaling Promotes CNS Axon Regeneration |
| 02/28/2008 | US20080051318 Detecting single nucleotide polymorphism ; kits; drug screening; neurodegenerative disease |
| 02/28/2008 | US20080050499 Process for preparing a composition comprising steroidal glycosides |
| 02/28/2008 | US20080050479 Food product & process for manufacturing same |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050456 Intramammary formulations |
| 02/28/2008 | US20080050454 Mixture of vitamins, minerals; for physiologically stressful states as pregnancy, lactation, nutritional deficiencies; nutraceuticals |
| 02/28/2008 | US20080050453 Comprises selenium, copper, zinc, manganese and/or chromium, and EDTA |
| 02/28/2008 | US20080050450 Active Agent Formulations, Methods of Making, and Methods of Use |
| 02/28/2008 | US20080050449 Controlled release formulation of tolterodine |
| 02/28/2008 | US20080050447 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080050444 Pharmaceutical compositions of ilaparazole |
| 02/28/2008 | US20080050443 Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing Thereof |
| 02/28/2008 | US20080050442 Nasal pharmaceutical formulations and methods of using the same |
| 02/28/2008 | US20080050441 Process for the preparation of solid sterile active pharmaceutical ingredient |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | US20080050437 a time-release composition comprising antithrombins such as (2S)-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-N-[[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]methyl]azetidine-2-carboxamide, hydroxy propyl methyl cellulose and sodium stearyl fumarate as a lubricant; cardiovascular disorder |
| 02/28/2008 | US20080050436 Methods and compounds for obliteration of vessels |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |